Abstract | PURPOSE: Many botanical immunomodulators are used as adjuvants along with cancer chemotherapy. However, information on the impact of concurrent administration of such botanicals on pharmacokinetics of chemotherapy agents is inadequate. This study investigates inhibitory activities of 3 popular botanical adjuvants: ASPARAGUS RACEMOSU: (root aqueous extract; ARE), WITHANIA SOMNIFER: (root aqueous extract; WSE), and TINOSPORA CORDIFOLI: (stem aqueous extract, TCE) on human CYP3A4 isoenzyme, responsible for metabolism of several chemotherapy agents. EXPERIMENTAL DESIG: . Testosterone 6-β hydroxylation was monitored using high-performance liquid chromatography as an indicator of CYP3A4 catalytic activities. Ketoconazole (positive control) and extracts were studied at their in vivo-relevant concentrations. RESULTS: TCE showed mild inhibition while no significant inhibitory activities were observed in WSE and ARE. TCE was further fractionated to obtain polar and nonpolar fractions. The nonpolar fraction showed significant CYP3A4 inhibition with IC50 13.06 ± 1.38 µg/mL. Major constituents of nonpolar fraction were identified using HPLC-DAD-MS profiling as berberine, jatrorrhizine, and palmatine, which showed IC50 values as 6.25 ± 0.30, 15.18 ± 1.59, and 15.53 ± 1.89 µg/mL, respectively. CONCLUSION:
|
Authors | Dada Patil, Manish Gautam, Sunil Gairola, Suresh Jadhav, Bhushan Patwardhan |
Journal | Integrative cancer therapies
(Integr Cancer Ther)
Vol. 13
Issue 2
Pg. 167-75
(Mar 2014)
ISSN: 1552-695X [Electronic] United States |
PMID | 24105360
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Cytochrome P-450 CYP3A Inhibitors
- Immunologic Factors
- Plant Extracts
- Cytochrome P-450 CYP3A
- CYP3A4 protein, human
|
Topics |
- Asparagus Plant
(chemistry)
- Cytochrome P-450 CYP3A
- Cytochrome P-450 CYP3A Inhibitors
- Humans
- Immunologic Factors
(pharmacology)
- Plant Extracts
(pharmacology)
- Tinospora
(chemistry)
- Withania
(chemistry)
|